[1] A. Compston, A. Coles, Multiple sclerosis, Lancet. 372 (2008) 1502–1517. https://doi.org/10.1016/S0140-6736(08)61620-7.
[2] M.M. Goldenberg, Multiple Sclerosis Review, Pharm. Ther. 37 (2012) 175. /pmc/articles/PMC3351877/ (accessed September 27, 2021).
[3] M.A. Moscarello, Myelin Basic Protein, the “Executive” Molecule of the Myelin Membrane, in: Cell Biol. Pathol. Myelin, 1997. https://doi.org/10.1007/978-1-4615-5949-8_2.
[4] P. Peschl, M. Bradl, R. Höftberger, T. Berger, M. Reindl, Myelin oligodendrocyte glycoprotein: Deciphering a target in inflammatory demyelinating diseases, Front. Immunol. 8 (2017) 1. https://doi.org/10.3389/fimmu.2017.00529.
[5] R. M, R.-J. P, M. DM, P. Y, A.-A. Y, R.-S. C, L. PSC, A. AA, G. ME, A. JM, Molecular mimicry and autoimmunity, J. Autoimmun. 95 (2018) 100–123. https://doi.org/10.1016/J.JAUT.2018.10.012.
[6] M.F. Cusick, J.E. Libbey, R.S. Fujinami, Molecular Mimicry as a Mechanism of Autoimmune Disease, Clin. Rev. Allergy Immunol. 42 (2012) 102. https://doi.org/10.1007/S12016-011-8294-7.
[7] H. Xu, M. Liu, J. Cao, X. Li, D. Fan, Y. Xia, X. Lu, J. Li, D. Ju, H. Zhao, Q. Guan, The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases, J. Immunol. Res. 2019 (2019). https://doi.org/10.1155/2019/7546047.
[8] S. Trott, I.L. King, An introduction to the microbiome and MS, Mult. Scler. (2018). https://doi.org/10.1177/1352458517737391.
[9] M.K. Smatti, F.S. Cyprian, G.K. Nasrallah, A.A. Al Thani, R.O. Almishal, H.M. Yassine, Viruses and autoimmunity: A review on the potential interaction and molecular mechanisms, Viruses. 11 (2019). https://doi.org/10.3390/v11080762.
[10] M. M, A. L, F. MF, C. J, The role of infections in multiple sclerosis, Mult. Scler. 25 (2019) 891–901. https://doi.org/10.1177/1352458518823940.
[11] J.R. Kerr, The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease, J. Clin. Pathol. (2016). https://doi.org/10.1136/jclinpath-2015-203455.
[12] D. Wang, P.W.L. Tai, G. Gao, Adeno-associated virus vector as a platform for gene therapy delivery, Nat. Rev. Drug Discov. (2019). https://doi.org/10.1038/s41573-019-0012-9.
[13] D.N. Posnett, Herpesviruses and autoimmunity, Curr. Opin. Investig. Drugs. 9 (2008) 505–514. https://europepmc.org/article/med/18465661 (accessed December 2, 2020).
[14] J. Gutiérrez, M.J. Vergara, M. Guerrero, O. Fernández, G. Piédrola, P. Morales, M. Del, Multiple sclerosis and human herpesvirus 6, Infection. (2002). https://doi.org/10.1007/s15010-002-2056-7.
[15] M. V. Tejada-Simon, Y.C.Q. Zang, J. Hong, V.M. Rivera, J.Z. Zhang, Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis, Ann. Neurol. (2003). https://doi.org/10.1002/ana.10425.
[16] P. Medveczky, J. Antal, A. Patthy, K. Kékesi, G. Juhász, L. Szilágyi, L. Gráf, Myelin basic protein, an autoantigen in multiple sclerosis, is selectively processed by human trypsin 4, FEBS Lett. 580 (2006) 545–552. https://doi.org/10.1016/j.febslet.2005.12.067.
[17] E. Miyauchi, S.W. Kim, W. Suda, M. Kawasumi, S. Onawa, N. Taguchi-Atarashi, H. Morita, T.D. Taylor, M. Hattori, H. Ohno, Gut microorganisms act together to exacerbate inflammation in spinal cords, Nature. (2020). https://doi.org/10.1038/s41586-020-2634-9.
[18] G. Mameli, E. Cocco, J. Frau, M.G. Marrosu, L.A. Sechi, Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients, Sci. Rep. 6 (2016). https://doi.org/10.1038/srep22401.
[19] C. D, M. G, G. G, C. E, M. S, F. J, M. MG, M. R, S. LA, Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients, Mult. Scler. 21 (2015) 984–995. https://doi.org/10.1177/1352458514557304.
[20] M. G, C. D, C. E, M. S, F. J, M. MG, S. LA, Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients, J. Neuroimmunol. 270 (2014) 51–55. https://doi.org/10.1016/J.JNEUROIM.2014.02.013.
[21] K.R. Rumah, J. Linden, V.A. Fischetti, T. Vartanian, Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease, PLoS One. 8 (2013). https://doi.org/10.1371/JOURNAL.PONE.0076359.
[22] S. Wagley, M. Bokori-Brown, H. Morcrette, A. Malaspina, C. D’Arcy, S. Gnanapavan, N. Lewis, M.R. Popoff, D. Raciborska, R. Nicholas, B. Turner, R.W. Titball, Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis, Mult. Scler. J. 25 (2019) 653–660. https://doi.org/10.1177/1352458518767327.
[23] M. Mateu-Salat, E. Urgell, A. Chico, SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19, J. Endocrinol. Investig. 2020 4310. 43 (2020) 1527–1528. https://doi.org/10.1007/S40618-020-01366-7.
[24] G. Halpert, Y. Shoenfeld, SARS-CoV-2, the autoimmune virus, Autoimmun. Rev. 19 (2020) 102695. https://doi.org/10.1016/J.AUTREV.2020.102695.
[25] M.C. Sacchi, S. Tamiazzo, P. Stobbione, L. Agatea, P. De Gaspari, A. Stecca, E.C. Lauritano, A. Roveta, R. Tozzoli, R. Guaschino, R. Bonometti, SARS-CoV-2 infection as a trigger of autoimmune response, Clin. Transl. Sci. 14 (2021) 898–907. https://doi.org/10.1111/CTS.12953.
[26] R. JM, K. DJ, H. PB, Bile salt biotransformations by human intestinal bacteria, J. Lipid Res. 47 (2006) 241–259. https://doi.org/10.1194/JLR.R500013-JLR200.
[27] J. Ochoa-Repáraz, D.W. Mielcarz, L.E. Ditrio, A.R. Burroughs, S. Begum-Haque, S. Dasgupta, D.L. Kasper, L.H. Kasper, Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression , J. Immunol. 185 (2010) 4101–4108. https://doi.org/10.4049/jimmunol.1001443.
[28] S. Gill, A. Christopher, V. Gupta, P. Bansal, Emerging role of bioinformatics tools and software in evolution of clinical research, Perspect. Clin. Res. (2016). https://doi.org/10.4103/2229-3485.184782.
[29] N. Petrovsky, V. Brusic, Bioinformatics for study of autoimmunity, Autoimmunity. 39 (2006) 635–643. https://doi.org/10.1080/08916930601062437.
[30] M. Trela, P.N. Nelson, P.B. Rylance, The role of molecular mimicry and other factors in the association of Human Endogenous Retroviruses and autoimmunity, APMIS. 124 (2016) 88–104. https://doi.org/10.1111/APM.12487.
[31] J. Jumper, R. Evans, A. Pritzel, T. Green, M. Figurnov, O. Ronneberger, K. Tunyasuvunakool, R. Bates, A. Žídek, A. Potapenko, A. Bridgland, C. Meyer, S.A.A. Kohl, A.J. Ballard, A. Cowie, B. Romera-Paredes, S. Nikolov, R. Jain, J. Adler, T. Back, S. Petersen, D. Reiman, E. Clancy, M. Zielinski, M. Steinegger, M. Pacholska, T. Berghammer, D. Silver, O. Vinyals, A.W. Senior, K. Kavukcuoglu, P. Kohli, D. Hassabis, Applying and improving AlphaFold at CASP14, Proteins Struct. Funct. Bioinforma. 89 (2021) 1711–1721. https://doi.org/10.1002/PROT.26257.
[32] J. Jumper, R. Evans, A. Pritzel, T. Green, M. Figurnov, O. Ronneberger, K. Tunyasuvunakool, R. Bates, A. Žídek, A. Potapenko, A. Bridgland, C. Meyer, S.A.A. Kohl, A.J. Ballard, A. Cowie, B. Romera-Paredes, S. Nikolov, R. Jain, J. Adler, T. Back, S. Petersen, D. Reiman, E. Clancy, M. Zielinski, M. Steinegger, M. Pacholska, T. Berghammer, S. Bodenstein, D. Silver, O. Vinyals, A.W. Senior, K. Kavukcuoglu, P. Kohli, D. Hassabis, Highly accurate protein structure prediction with AlphaFold, Nat. 2021 5967873. 596 (2021) 583–589. https://doi.org/10.1038/s41586-021-03819-2.
[33] V.A. Simossis, J. Heringa, PRALINE: A multiple sequence alignment toolbox that integrates homology-extended and secondary structure information, Nucleic Acids Res. (2005). https://doi.org/10.1093/nar/gki390.
[34] P. Bawono, J. Heringa, PRALINE: A versatile multiple sequence alignment toolkit, Methods Mol. Biol. 1079 (2014) 245–262. https://doi.org/10.1007/978-1-62703-646-7_16.
[35] H. Land, M.S. Humble, YASARA: A tool to obtain structural guidance in biocatalytic investigations, in: Methods Mol. Biol., Humana Press Inc., 2018: pp. 43–67. https://doi.org/10.1007/978-1-4939-7366-8_4.
[36] J.R. Kerr, The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease, J. Clin. Pathol. 69 (2016) 279–291. https://doi.org/10.1136/JCLINPATH-2015-203455.
[37] L. Kular, Y. Liu, S. Ruhrmann, G. Zheleznyakova, F. Marabita, D. Gomez-Cabrero, T. James, E. Ewing, M. Lindén, B. Górnikiewicz, S. Aeinehband, P. Stridh, J. Link, T.F.M. Andlauer, C. Gasperi, H. Wiendl, F. Zipp, R. Gold, B. Tackenberg, F. Weber, B. Hemmer, K. Strauch, S. Heilmann-Heimbach, R. Rawal, U. Schminke, C.O. Schmidt, T. Kacprowski, A. Franke, M. Laudes, A.T. Dilthey, E.G. Celius, H.B. Søndergaard, J. Tegnér, H.F. Harbo, A.B. Oturai, S. Olafsson, H.P. Eggertsson, B. V. Halldorsson, H. Hjaltason, E. Olafsson, I. Jonsdottir, K. Stefansson, T. Olsson, F. Piehl, T.J. Ekström, I. Kockum, A.P. Feinberg, M. Jagodic, DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis, Nat. Commun. 2018 91. 9 (2018) 1–15. https://doi.org/10.1038/s41467-018-04732-5.
[38] S. Paul, C.S. Lindestam Arlehamn, T.J. Scriba, M.B.C. Dillon, C. Oseroff, D. Hinz, D.M. McKinney, S. Carrasco Pro, J. Sidney, B. Peters, A. Sette, Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes, J. Immunol. Methods. 422 (2015) 28–34. https://doi.org/10.1016/J.JIM.2015.03.022.
[39] T.R. KLAENHAMMER, C. FREMAUX, C. AHN, K. MILTON, Molecular Biology of Bacteriocins Produced by Lactobacillus, in: Bacteriocins Lact. Acid Bact., Elsevier, 1993: pp. 151–180. https://doi.org/10.1016/b978-0-12-355510-6.50015-4.
[40] N.A. Abreu, N.A. Nagalingam, Y. Song, F.C. Roediger, S.D. Pletcher, A.N. Goldberg, S. V. Lynch, Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis, Sci. Transl. Med. 4 (2012) 151ra124. https://doi.org/10.1126/scitranslmed.3003783.
[41] C. Montanari, F. Barbieri, M. Magnani, L. Grazia, F. Gardini, G. Tabanelli, Phenotypic diversity of Lactobacillus sakei strains, Front. Microbiol. 9 (2018) 2003. https://doi.org/10.3389/fmicb.2018.02003.
[42] M. Takeda, H. Makita, K. Ohno, Y. Nakahara, J.I. Koizumi, Structural analysis of the sheath of a sheathed bacterium, Leptothrix cholodnii, Int. J. Biol. Macromol. 37 (2005) 92–98. https://doi.org/10.1016/j.ijbiomac.2005.09.002.
[43] E. Mani-López, E. Palou, A. López-Malo, Biopreservatives as Agents to Prevent Food Spoilage, in: Microb. Contam. Food Degrad., Elsevier, 2018: pp. 235–270. https://doi.org/10.1016/b978-0-12-811515-2.00008-1.
[44] A.D. Hocking, Aspergillus and related teleomorphs, in: Food Spoilage Microorg., Elsevier Ltd, 2006: pp. 451–487. https://doi.org/10.1533/9781845691417.4.451.
[45] O. Puel, P. Galtier, I.P. Oswald, Biosynthesis and toxicological effects of patulin, Toxins (Basel). 2 (2010) 613–631. https://doi.org/10.3390/TOXINS2040613.
[46] S. DasSarma, J.A. Coker, P. DasSarma, Archaea (overview), in: Encycl. Microbiol., Elsevier Inc., 2009: pp. 1–23. https://doi.org/10.1016/B978-012373944-5.00108-5.
[47] W.K. Nip, F.S. Chu, Production of [14C]patulin by Penicillium patulum, Appl. Environ. Microbiol. 33 (1977) 814–816. https://doi.org/10.1128/aem.33.4.814-816.1977.
[48] D. Errampalli, Penicillium expansum (Blue Mold), in: Postharvest Decay Control Strateg., Elsevier Inc., 2014: pp. 189–231. https://doi.org/10.1016/B978-0-12-411552-1.00006-5.
[49] J.A. Sugui, K.J. Kwon-Chung, P.R. Juvvadi, J.-P. Latgé, W.J. Steinbach, Aspergillus fumigatus and Related Species, Cold Spring Harb. Perspect. Med. 5 (2015). https://doi.org/10.1101/CSHPERSPECT.A019786.
[50] S. Suster, C.A. Moran, *Klebsiella* Pneumonia, Diagnostic Pathol. Thorac. (2017) 530–533. https://doi.org/10.1016/B978-0-323-37715-7.50113-4.
[51] E.A. Johnson, C. Echavarri-Erasun, Yeast Biotechnology, The Yeasts. 1 (2011) 21–44. https://doi.org/10.1016/B978-0-444-52149-1.00003-3.
[52] D. P, M. E, Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence, Clin. Microbiol. Infect. 16 (2010) 821–830. https://doi.org/10.1111/J.1469-0691.2010.03237.X.
[53] A. Haraga, T.E. West, M.J. Brittnacher, S.J. Skerrett, S.I. Miller, Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of burkholderia pseudomallei, Infect. Immun. 76 (2008) 5402–5411. https://doi.org/10.1128/IAI.00626-08.
[54] A.T. Harrington, J.A. Castellanos, T.M. Ziedalski, J.E. Clarridge, III, B.T. Cookson, Isolation of Bordetella avium and Novel Bordetella Strain from Patients with Respiratory Disease, Emerg. Infect. Dis. 15 (2009) 72. https://doi.org/10.3201/EID1501.071677.
[55] A.J. Chaves Hernández, Poultry and Avian Diseases, Encycl. Agric. Food Syst. (2014) 504–520. https://doi.org/10.1016/B978-0-444-52512-3.00183-2.
[56] C.T. Dow, Mycobacterium avium Subspecies Paratuberculosis and Human Disease: Bridging Infection and Autoimmunity, Infect. Autoimmun. (2015) 569–581. https://doi.org/10.1016/B978-0-444-63269-2.00037-4.
[57] Y. Yu, L. You, D. Liu, W. Hollinshead, Y.J. Tang, F. Zhang, Development of Synechocystis sp. PCC 6803 as a Phototrophic Cell Factory, Mar. Drugs. 11 (2013) 2894. https://doi.org/10.3390/MD11082894.
[58] D. Hu, S.M.-Y. Lee, K. Li, K.M. Mok, Secondary Metabolite Production Potential of Mangrove-Derived Streptomyces olivaceus, Mar. Drugs 2021, Vol. 19, Page 332. 19 (2021) 332. https://doi.org/10.3390/MD19060332.
[59] R. Azevedo, J.L. Lopes, M.M. de Souza, B.F. Quirino, L.J. Cançado, L.F. Marins, Synechococcus elongatus as a model of photosynthetic bioreactor for expression of recombinant β-glucosidases, Biotechnol. Biofuels 2019 121. 12 (2019) 1–10. https://doi.org/10.1186/S13068-019-1505-9.
[60] L. Moutsianas, L. Jostins, A.H. Beecham, A.T. Dilthey, D.K. Xifara, M. Ban, T.S. Shah, N.A. Patsopoulos, L. Alfredsson, C.A. Anderson, K.E. Attfield, S.E. Baranzini, J. Barrett, T.M.C. Binder, D. Booth, D. Buck, E.G. Celius, C. Cotsapas, S. D’Alfonso, C.A. Dendrou, P. Donnelly, B. Dubois, B. Fontaine, L. Fugger, A. Goris, P.-A. Gourraud, C. Graetz, B. Hemmer, J. Hillert, I.I.G.C. (IIBDGC), I. Kockum, S. Leslie, C.M. Lill, F. Martinelli-Boneschi, J.R. Oksenberg, T. Olsson, A. Oturai, J. Saarela, H.B. Søndergaard, A. Spurkland, B. Taylor, J. Winkelmann, F. Zipp, J.L. Haines, M.A. Pericak-Vance, C.C.A. Spencer, G. Stewart, D.A. Hafler, A.J. Ivinson, H.F. Harbo, S.L. Hauser, P.L. De Jager, A. Compston, J.L. McCauley, S. Sawcer, G. McVean, Class II HLA interactions modulate genetic risk for multiple sclerosis, Nat. Genet. 47 (2015) 1107. https://doi.org/10.1038/NG.3395.
[61] M.C. Jespersen, B. Peters, M. Nielsen, P. Marcatili, BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes, Nucleic Acids Res. 45 (2017) W24–W29. https://doi.org/10.1093/NAR/GKX346.
[62] H. FF, S. L, S. C, B. M, S. C, Pyruvate Substitutions on Glycoconjugates, Int. J. Mol. Sci. 20 (2019). https://doi.org/10.3390/IJMS20194929.
[63] M.E. Mead, S.L. Knowles, H.A. Raja, S.R. Beattie, C.H. Kowalski, J.L. Steenwyk, L.P. Silva, J. Chiaratto, L.N.A. Ries, G.H. Goldman, R.A. Cramer, N.H. Oberlies, A. Rokas, Characterizing the Pathogenic, Genomic, and Chemical Traits of Aspergillus fischeri , a Close Relative of the Major Human Fungal Pathogen Aspergillus fumigatus , MSphere. 4 (2019). https://doi.org/10.1128/MSPHERE.00018-19/SUPPL_FILE/MSPHERE.00018-19-SF007.PDF.
[64] B.R. Shruthi, R.N.H. Achur, T. Nayaka Boramuthi, Optimized Solid-State Fermentation Medium Enhances the Multienzymes Production from Penicillium citrinum and Aspergillus clavatus, Curr. Microbiol. 2020 779. 77 (2020) 2192–2206. https://doi.org/10.1007/S00284-020-02036-W.
[65] T. Jin, X. Xu, J. Fang, N. Isik, J. Yan, J.A. Brzostowski, D. Hereld, How human leukocytes track down and destroy pathogens: lessons learned from the model organism Dictyostelium discoideum, Immunol. Res. 2008 431. 43 (2008) 118–127. https://doi.org/10.1007/S12026-008-8056-7.
[66] M.P. Hosking, T.E. Lane, The pathogenesis of murine coronavirus infection of the central nervous system, Crit. Rev. Immunol. 30 (2010) 119–130. https://doi.org/10.1615/CRITREVIMMUNOL.V30.I2.20.
[67] S.P. Templeton, S. Perlman, Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM, Immunol. Res. 39 (2007) 160–172. https://doi.org/10.1007/s12026-007-0079-y.
[68] J.J. Phillips, M.M. Chua, S.H. Seo, S.R. Weiss, Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence, J. Neurovirol. 7 (2001) 421. https://doi.org/10.1080/135502801753170273.
[69] SARS-CoV-2 infection and persistence throughout the human body and brain, (2021). https://doi.org/10.21203/RS.3.RS-1139035/V1.